Caution urged when considering changes in diabetes care for women of child-bearing age Study shows women undergoing menopause can ward off metabolic syndrome Insulin pumps have most reported problems in FDA database Empagliflozin improves survival in type 2 diabetes patients with established cardiovascular disease Estimated to improve life expectancy by one to 4.5 years according to an analysis of data from a major trial Pharmacologic management of type 2 diabetes New developments in type 2 diabetes care Montreal diabetes prevention clinic said to be first of its kind in Canada Study examines risk of serious adverse events with SGLT2 inhibitors in type 2 diabetes Finds twofold increases in the risk of lower limb amputation and diabetic ketoacidosis 2018 Consolidated Canadian guideline for preventing and managing cardiovascular disease in primary care C-CHANGE guideline combines recommendations from nine Canadian cardiovascular-related guidelines to meet primary care needs Pharmacist pushes for free access to insulin pen needles in Ontario In a quest to get insulin pen needles covered under Ontario’s provincial drug plan, one pharmacist is taking matters into her own hands. First Previous 18 19 20 21 22 Next Last
